Bionorica SE is one of the leading companies in the area of phytopharmaceuticals worldwide. With phytoneering Bionorica establishs a new future field in the field of pharmacy. Phytoneering combines the huge potential of natural active substances (phytos) with the knowledge and technology of modern pharmaceutical research (engineering) fot the production of effective and safe drugs. Bionorica studies the complex, active substances of medical plants for the production of phytopharmaka for decades. This phytopharmaka are in no way inferior to chemical-synthetic drugs in terms of effectiveness and have less side effects.
Core Technologies and Services
The research focus of Bionorica is mainly in the area of the respiratory tract, urinary tract, gynecology and the immune system complemented with products which target the liver or deal with rheuma and sleep. The whole complex process, from the development of the relevant seeds to the production of the drugs is normalized and standardized and get’s controlled constantly. These essential steps include appropriate plant harvesting and drying methods, an optimized extraction process, the development of effective galenics and an innovative packaging technology for the final products.
Patent, Licenses, Co-operations
Bionorica has established an impressive network of scientists working in about 500 renowned universities, clinics and institutions worldwide. The result of continuous development, exchange of ideas and successful co-operations in Germany and abroad is documented in more than 30 patents.
Bionorica is a marketing authorisation holder in more than 50 countries all over the world. Marketing and sales in foreign countries are carried out by subsidiaries or contractual partners.